Tilray | Revenu Net

Prix De L'Action
10.70
Variation Quotidienne
-0.15 -1.38%
Mensuellement
-11.13%
Annuel
838.60%
Q1 Prévisions
10.37




Revenu Net Changement Date
Acasti Pharma USD -938K 2.42M 2025-09
Akebia Therapeutics USD 6.11M 28.92M 2025-03
Alaunos Therapeutics USD -1.16M 417K 2025-09
Aurora Cannabis CAD -51.47M 36.26M 2025-09
Avita Medical AUD -9.92M 1.67M 2025-06
Canopy Growth CAD -1.64M 39.89M 2025-09
Cronos Group USD -25.96M 13.75M 2025-09
Dianthus Therapeutics USD -36.76M 5.13M 2025-09
Divis Laboratories Ltd INR 5.83B 1.06B 2025-12
Ionis Pharmaceuticals USD -229M 100.39M 2025-12
IQVIA Holdings USD 514M 183M 2025-12
Knight Therapeutics CAD 85K 2.03M 2024-09
Moderna USD -200M 625M 2025-09
Organigram Holdings CAD -37.96M 31.67M 2025-09
Organon & Co USD 160M 15M 2025-09
Revvity USD 98.36M 51.71M 2025-12
Tectonic Therapeutic USD -19.04M 940K 2025-09
Tilray USD -44.93M 44.61M 2025-09
Viatris USD -128.2M 123.6M 2025-09
Xeris Pharmaceuticals USD 621K 2.55M 2025-09


Tilray Revenu Net - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.